Clinical Trial Update: A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating adebrelimab plus apatinib mesylate and chemotherapy as neoadjuvant therapy for limited-stage small cell lung cancer, with biomarker ana…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib Mesylate (apatinib)

Snippet

Sponsor: Jin Ying | Conditions: Small Cell Lung Cancer Limited Stage | Phase 2 | Status: RECRUITING